Title |
Giant osteoclasts in patients under bisphosphonates
|
---|---|
Published in |
BMC Clinical Pathology, July 2014
|
DOI | 10.1186/1472-6890-14-31 |
Pubmed ID | |
Authors |
Fabrice Mac-Way, Andrea Trombetti, Christian Noel, Marie-Hélène Lafage-Proust |
Abstract |
Bisphosphonates have been widely used for treatment of high bone resorption states. It lowers bone turnover by inhibiting osteoclasts bone resorption with various mechanisms of actions: inhibition of osteoclast formation and attachment to the bone surface, induction of metabolic injury, alteration of vesicle trafficking and induction of osteoclast apoptosis. Bone biopsies studies from patients under bisphosphonates have shown that some resorption parameters are decreased as expected but the number of osteoclasts seems not to be necessarily decreased. The description of osteoclasts morphology from patients treated with bisphosphonates has rarely been reported in the literature. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 7 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 3 | 43% |
Professor | 1 | 14% |
Other | 1 | 14% |
Professor > Associate Professor | 1 | 14% |
Unknown | 1 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 4 | 57% |
Agricultural and Biological Sciences | 1 | 14% |
Unknown | 2 | 29% |